Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Gaucho Group Holdings Stockholders Deficiency [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Gaucho Group Holdings Stockholders Deficiency [Member]
Noncontrolling Interest [Member]
Total
Balance - January 1, 2022 at Dec. 31, 2021                 $ 8,235 $ (46,355) $ 121,633,826 $ (11,607,446) $ (95,726,534) $ 14,261,726 $ (169,882) $ 14,091,844
Beginning balance, shares at Dec. 31, 2021                 823,496 281            
Stock-based compensation:                                
Options                 72,700 72,700 10,354 83,054
Common stock issued for 401(k) employer matching                 $ 10 27,811 27,821 $ 27,821
Common stock issued for 401(k) employer matching, shares                 1,040             1,040
Net loss                 (2,199,840) (2,199,840) (72,261) $ (2,272,101)
Other comprehensive income                 263,406 263,406 263,406
Common stock issued for purchase of minority interest                 $ 869 (232,658) (231,789) 231,789
Common stock issued for purchase of minority interest, shares                 86,899              
Common stock issued for  acquisition of GDS                 $ 1,070 2,193,583 2,194,653 2,194,653
Common stock issued for acquisition of GDS, shares                 106,952              
Common stock issued for purchase of domain name                 $ 13 39,587 39,600 39,600
Common stock issued for purchase of domain name, shares                 1,250              
Warrants issued for  modification of convertible debt principal                 731,856 731,856 731,856
Ending balance, value at Mar. 31, 2022                 $ 10,197 $ (46,355) 124,466,705 (11,344,040) (97,926,374) 15,160,133 15,160,133
Ending balance, shares at Mar. 31, 2022                 1,019,637 281            
Balance - January 1, 2022 at Dec. 31, 2022                 $ 36,534 $ (46,355) 139,123,642 (10,842,569) (117,479,571) 10,791,681
Beginning balance, shares at Dec. 31, 2022                 3,653,401 281            
Cumulative effect of change upon adoption of ASU 2016-13 $ (111,582) $ (111,582)                
Stock-based compensation:                                
Options                 38,834     38,834
Restricted stock units                 $ 39 79,383     79,422
Stock Issued During Period, Shares, Restricted Stock Award, Gross                 3,890              
Common stock issued for 401(k) employer matching                 $ 242 32,375     $ 32,617
Common stock issued for 401(k) employer matching, shares                 24,160             24,160
Shares issued under the New ELOC, net of offering costs [1]                 $ 3,644 437,765     $ 441,409
Stock Issued During Period, Shares, New Issues                 364,430              
Relative fair value of warrants issued with 2023 Notes, net of issuance costs [2]                 1,506,319     1,506,319
Warrants issued for modification of GGH Notes                 134,779     134,779
Reduction of warrant exercise price on new debt issuance                 63,502     63,502
Shares issued upon conversion of debt and interest                 $ 8,333 1,563,220     1,571,553
Shares issued upon conversion, shares                 833,333              
Common stock issued for cash in private placement                 $ 5,910 585,090     591,000
Stock Issued During Period, Shares, Other                 591,000              
Cashless warrant exercise                 $ 513 (513)    
Cashless warrant exercise, shares                 51,305              
True-up adjustment                    
True-up adjustment, shares                 281              
Net loss                 (2,695,148) (2,695,148)
Other comprehensive income                 (39,799)     (39,799)
Ending balance, value at Mar. 31, 2023                 $ 55,215 $ (46,355) $ 143,564,396 $ (10,882,368) $ (120,286,301) $ 12,404,587
Ending balance, shares at Mar. 31, 2023                 5,521,800 281            
[1] Includes gross proceeds of $480,670, less $39,261 offering costs
[2] Represents $1,609,935 relative fair value of warrants, less $103,616 of allocable issuance costs